Come up with a name for your new list and we'll add to it:
Verrica Pharmaceuticals raised a round of funding on February 21, 2018. Investors include
PBM Capital Group.
Verrica Pharmaceuticals (NASDAQ: VRCA) is a pharmaceutical company developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plant…